[Purulent meningitis in Denmark].
The epidemiology of meningococcal disease in Denmark has changed in recent years, with a rise in the number of cases in the 14-18 year age group. During the last decade 80 per cent of the meningococci belonged to Group B and 20 per cent to Group C. The treatment has followed the lines of the recommendations issued by the Rigshospitalet but some hospital departments have now chosen other preparations, as appears from the study presented in the article.
Eriksen
N H
NH
Klinisk mikrobiologisk afd, Københavns Amts Sygehus i Herlev.
Scheibel
J
J
Vejlsgaard
R
R
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D002648:Child; D003718:Denmark / Q000453:epidemiology; D006801:Humans; D008581:Meningitis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D013492:Suppuration
D000900:Anti-Bacterial Agents
Purulent meningitis i Danmark.